Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Former Biogen Exec Launches First Life Sciences Fund With $750 Million May 22, 2017 Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 January 1, 2018 Mesa Labs Declares Quarterly Dividend October 2, 2017
